Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial.

@article{Exter2016EfficacyAS,
  title={Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial.},
  author={Paul L. den Exter and Wendy Zondag and Frederikus A Klok and Rolf E. Brouwer and Janneke Dolsma and Michiel M. M. Eijsvogel and Laura Faber and Marijke van Gerwen and Marco J. J. H. Grootenboers and Roxane Heller-Baan and Marcel M. C. Hovens and G{\'e} J P M Jonkers and Klaas W. van Kralingen and Christian F. Melissant and Henny G Peltenburg and Judith P Post and Marcel A van de Ree and L Th Tom Vlasveld and Mari{\"e}lle J M de Vreede and Menno V. Huisman},
  journal={American journal of respiratory and critical care medicine},
  year={2016},
  volume={194 8},
  pages={998-1006}
}
RATIONALE Outpatient treatment of pulmonary embolism (PE) may lead to improved patient satisfaction and reduced healthcare costs. However, trials to assess its safety and the optimal method for patient selection are scarce. OBJECTIVES To validate the utility and safety of selecting patients with PE for outpatient treatment by the Hestia criteria and to… CONTINUE READING